Wednesday, October 13, 2021 4:51:41 PM
The ACTIV-5 trial is ongoing. It isn't normal to unblind data while a trial is in progress. Durrant said they would first submit non-ACTIV-5 data to try for the EUA. Then they would submit ACTIV-5 trial data when it completed. The one thing that does jive with the ACTIV-5 trial is that they are submitting data from 200 patients. There might have been an interim analysis at 200 patients since there was an interim analysis at 100 patients and the original trial was designed for 200 patients.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM